104 results
Page 5 of 6
8-K
atadd uvcki7xmc99wa
27 Apr 20
Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data for a Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer
8:00am
8-K
EX-99.1
svyb109xkr6rklv
27 Apr 20
Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data for a Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer
8:00am
8-K
EX-99.1
gwmdsy0f9j40k80td
16 Mar 20
Sutro Biopharma Reports Full Year 2019 Financial Results
6:04am
8-K
EX-99.1
acv lg709xbjm
8 Nov 19
Sutro Biopharma Reports Third Quarter 2019 Financial Results
8:00am
8-K
EX-99.1
9j2o zqz9tppcpnb67
30 Oct 19
Data is being presented as a poster today at AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference in Boston
12:00am
424B5
lqs1my0 u2gmv48ltr
11 Oct 19
Prospectus supplement for primary offering
4:22pm
S-3
5qp32d liytsd6y5sw7y
4 Oct 19
Shelf registration
4:06pm
S-3
EX-1.2
t3yq zwmn0lu2o
4 Oct 19
Shelf registration
4:06pm
8-K
EX-99.1
348e1
14 Aug 19
Sutro Biopharma Reports Second Quarter 2019 Financial Results
12:00am
8-K
EX-99.1
837abu 6b719rv7mqmn8
15 May 19
Sutro Biopharma Reports First Quarter 2019 Financial Results
7:00am
8-K
kioidhq2m3zmwv4g6qns
7 May 19
Other Events
12:00am
8-K
EX-99.1
gfs yufrug4q
1 Apr 19
Sutro Biopharma Reports Full Year 2018 Financial Results
10:22am
10-K
xn7q3li3qb
1 Apr 19
Annual report
12:00am
8-K
EX-99.1
vhfogial6 3o1f2
15 Nov 18
Sutro Biopharma Reports Third Quarter 2018 Financial Results
12:00am
10-Q
bgxir t0p1t4
14 Nov 18
Quarterly report
12:00am